You have 9 free searches left this month | for more free features.

City

Austin (1)

Winston-Salem (1)

Condition

Macular Degeneration (2)

Age-related Macular Degeneration (1)

Choroidal Neovascularization (1)

Cystoid Macular Edema (1)

Neovascular Macular Degeneration (1)

Uveitis (1)

Overall Status

Completed (3)

Sign in for free

Phase

n/a (1)

phase 3 (1)

Sponsor

Novartis Pharmaceuticals (1)

Pfizer (1)

Wake Forest University (1)

Collaborator

QLT Inc. (1)

Intervention

pegaptanib (3)

triamcinolone acetonide (1)

verteporfin photodynamic therapy (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

pegaptanib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

Completed

Has Results

Uveitis
Cystoid Macular Edema

Pegaptanib

Winston-Salem, North Carolina

Wake Forest University Eye Center

Mar 7, 2022

Macular Degeneration, Choroidal Neovascularization Trial in Austin (Verteporfin photodynamic therapy, Pegaptanib, Triamcinolone

Completed

Has Results

Macular Degeneration
Choroidal Neovascularization

Verteporfin photodynamic therapy
+2 more

Austin, Texas

Novartis Investigational Site

Mar 3, 2016

The Long-Term Effect Of Macugen In Wet Age-Related Macular

Completed

Has Results

Macular Degeneration
+2 more

Pegaptanib

(no location specified)

Jan 12, 2011